Jeffrey Okoro, of CFK Africa, tells Rachel Hagan that the drug lenacapavir can be transformative, but Kenya’s rollout is not yet reaching those who need it most
Notifications can be managed in browser preferences.
Swipe for next article
Jeffrey Okoro, of CFK Africa, tells Rachel Hagan that the drug lenacapavir can be transformative, but Kenya’s rollout is not yet reaching those who need it most
Removed from bookmarks
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
A year after the government announced a 40 per cent reduction in international development aid, Kristine Yakhama writes about the…
Rachel Hagan speaks to some of researchers behind the push for a full HIV vaccine – whose trial had to be saved after the US…
The Independent’s Bel Trew tells parliament’s International Development Select Committee that our call to protect funding could…
Campaigners warn a quarter of people who are more likely to develop HIV need better access to preventative drugs
Millions of people, particularly in African countries, have lost access to drug treatments, prevention and testing putting the…
Britain has significantly slashed its contribution to the Global Fund to fight AIDS, Tuberculosis and Malaria – compounding aid…
